fbpx

Professional Practice Standards for the future launched at PSA23

28 July 2023

 

The Pharmaceutical Society of Australia (PSA) has launched a reimagined Professional Practice Standards today at its national flagship conference, PSA23.

 

The Professional Practice Standards have undergone a dramatic rebuild, making them more flexible to meet the diverse and contemporary needs of pharmacists practising in different specialty areas and scopes.

 

Under the new Professional Practice Standards, each clinical activity undertaken by pharmacists falls into one or more of 17 standards that are built off the medicine management cycle. Applying the PPS to practice will require pharmacists to look at the clinical activities they undertake, and the minimum practice standards that apply to those activities.

 

PSA National President Dr Fei Sim FPS launched the standards as part of her address at PSA23, the national flagship conference of PSA, in front of pharmacists, organisation leaders, and government officials.

 

“Over the past few years, we have seen significant expansion of the roles of pharmacists in Australia. As we work towards enabling pharmacists to practice to full scope, we must be mindful that the practice of pharmacists must be underpinned by a robust set of standards, to ensure the quality of the work that we do.

 

“At its core, the PPS are designed to define and articulate the minimum expected standards of professional behaviour in all aspects of pharmacy practice,” Dr Sim said.

 

“Pharmacists should be everywhere that medicines are, at all stages of the Medicine Management Cycle. We are giving pharmacists the flexibility to build their standards based on their individual practice.

 

“Every pharmacist in Australia will be united by these standards, which gives us all the building blocks for the foundations of professional pharmacy practice.

 

“The standards support us to be more flexible, to confidently expand our scope when our practice evolves. It offers clear and actionable direction, and importantly, it ensures the quality and standard, and increases the safety and effectiveness of the services we provide.”

 

Chair of the Project Advisory Group, Deanna Mill MPS, considers it to be one of the most important projects to set up the future of the profession.

 

“Through careful collaboration with stakeholders and consumers, we have developed a contemporary and evidence-based resource that provides improved clarity and usability for pharmacists across different roles, practice settings and career stages.

 

“I encourage all pharmacists to use the newly revised and updated Professional Practice Standards as a contemporary, evidence-based resource to guide their quality professional practice. By incorporating these standards into daily practice, we can all deliver safe, effective, and person-centred care for all Australians.”

 

PSA thanks members of the Project Advisory Group, the Standard Review Group, and the PSA Project Team, as well as the pharmacists, consumer representatives, regulators, educators, researchers, and government agencies who contributed to the development of the Professional Practice Standards.

 

The Professional Practice Standards are available to pharmacists and the public here.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Ogundipe appointed as ECP Board Director

21 July 2023

 

The Pharmaceutical Society of Australia (PSA) today announces the appointment of Ayomide Ogundipe MPS as the National Board’s Early Career Pharmacist Board Director.

 

Ms Ogundipe was appointed following the conclusion of the former Director Deanna Mill’s term.

 

Ayomide is a community pharmacist, researcher and academic based in Perth, Western Australia. Since graduating from Curtin University in 2017, Ayomide has developed her practice in a range of areas. She is particularly passionate about digital health transformation, currently researching the technological needs of pharmacists to enable contemporary pharmacy practice in current and emerging roles.

 

PSA Chief Executive Officer Adj A/Prof Steve Morris welcomed Ms Ogundipe to the Board, and thanked Deanna Mill for her service since 2021.

 

“We’re proud to elevate ECP voices on the PSA Board, ensuring that we are best supporting pharmacists at all stages of their careers,” Adj A/Prof Morris said.

 

“Ayomide brings a depth of experience to the PSA Board, in addition to her role as Vice-President of PSA’s Western Australia branch.

 

“I look forward to working with her to continue Deanna’s work in advocating for and leading PSA’s Early Career Pharmacists.”

 

“I wish Deanna all the best for what comes next, and sincerely thank her for her outstanding work over the last two years, including chairing the Early Career Pharmacist Community of Specialty Interest.

 

“Deanna has also played a significant role in the development of reimagined Professional Practice Standards that will be launched at PSA23, including as Chair of the Project Advisory group.

 

“On behalf of the PSA Board, we thank Deanna for her contributions to our organisation,” Adj A/Prof Morris concluded.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

 

Pharmacists thank Rockliff for service to Health portfolio

21 July 2023

 

The Pharmaceutical Society of Australia (PSA) has thanked Tasmanian Premier Jeremy Rockliff for his leadership of the health sector over his years as Health Minister.

 

The Premier announced yesterday that he will step down as Health Minister, with a successor to be announced in the coming days.

 

PSA Tasmanian President David Peachey MPS thanked the Premier, drawing on his commitment to expanding pharmacy practice to better serve Tasmanians.

 

“Premier Rockliff has always been a great supporter of pharmacists, working with us to work closer to our top of scope and support the health of Tasmanians,” Mr Peachey said.

 

“We are proud to have worked with the Premier to progress the Review of pharmacists’ scope of practice in Tasmania, which will result in more health services being provided by pharmacists around our state.

 

“Under the Premier’s leadership Tasmanians have greater access to vaccinations through their local pharmacist and can also access a new supply of their medicines in an emergency through expanded continued dispensing.

 

“These initiatives are having a real and positive impact on the health of our communities.”

 

“On behalf of all pharmacists in Tasmania, I thank the Premier for his service as Health Minister.

 

“I look forward to continue working with him and his successor to continue work on supporting pharmacists’ scope of practice and ensuring that our primary care system delivers quality healthcare for all Tasmanians,” Mr Peachey concluded.

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Free influenza vaccinations from Queensland pharmacists

17 July 2023

 

The Pharmaceutical Society of Australia (PSA) welcomes Queensland Health Shannon Fentiman’s announcement of state-wide, no-cost influenza vaccinations for Queenslanders.

 

PSA Queensland President Shane MacDonald MPS said that the move will encourage more Queenslanders to make influenza vaccination a part of their regular health care.

 

“All Queensland age groups have the lowest or second-lowest influenza vaccination coverage of any state or territory this year,” Mr MacDonald said.

 

“Particularly at risk are young children, of which less than 20 per cent are vaccinated against influenza in 2023. Vaccination rates among Queenslanders aged 5 to 15 years is the lowest in Australia, sitting at just 11.1 per cent.

 

“We have already seen the deadly impact of low vaccination rates across the country, and if we don’t act now it will only get worse.

 

“Removing cost barriers and giving Queenslanders greater access to vaccines through community pharmacies is a great first step to improving vaccine uptake,” Mr MacDonald said.

 

“Pharmacists are able to vaccinate patients 6 months and over, meaning many families can come into their pharmacy together for their flu vaccines.

 

“With the flu season now in full swing, we need to do everything we can to protect Australian children by increasing access to vaccination and providing Queensland families with optimal protection against this deadly disease.

 

“As pharmacists we have demonstrated the crucial role we continue to play in protecting the health of Australians. We must do better than this to protect the most vulnerable in our communities.

 

“Pharmacists are practicing in almost every community from Brisbane to Cape York, supporting the health and wellbeing of our patients.

 

“Our message to all Queenslanders is simple, visit your local pharmacist and get your influenza vaccine,” Mr MacDonald concluded.

 

Data from NCIRS (accessed 17 July 2023)

https://ncirs.org.au/influenza-vaccination-coverage-data

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

 

JOINT MEDIA RELEASE: MSAC support funding pharmacists in First Nations Primary Health Services

 

12 July 2023

 

The Pharmaceutical Society of Australia (PSA) and the National Aboriginal Community Controlled Health Organisation (NACCHO) have welcomed today’s release of Medical Services Advisory Committee (MSAC) advice supporting funding to embed non-dispensing pharmacists within Aboriginal Health Services.

 

Australia’s principal medical advisory group’s recommendation is based on a joint submission from PSA, NACCHO and James Cook University (JCU) calling for funding for the Integrating Pharmacists within Aboriginal Community Controlled Health Services to improve Chronic Disease Management (IPAC) project.

 

The IPAC project integrated 26 pharmacists into 18 Aboriginal Community Controlled Health Organisations for 15 months across Queensland, Victoria, and the Northern Territory. Through the project, some Aboriginal Community Controlled Health Services embedded pharmacists directly into their services, while others worked with community pharmacies to deliver pharmacy services.

 

The independent expert advice recognises the significant impact pharmacists can have when integrated into comprehensive primary healthcare teams.

 

MSAC considered that the model was safe and effective compared to usual care. MSAC considered that the estimated costs for providing this integrated, collaborative, culturally appropriate patient-centred care to improve health outcomes for Aboriginal and Torres Strait Islander peoples was good value for money.

 

NACCHO and PSA are looking forward to working with government on rolling-out this important service nationally. PSA and NACCHO also recognise the leadership of JCU on this work that has led to this successful outcome.

 

Quotes attributable to the Chair of NACCHO Donnella Mills

 

“Aboriginal and Torres Strait Islander peoples continue to experience a higher burden of chronic disease due to cardiovascular, diabetes and other health problems than other Australians. 

 

“We are thrilled that that this independent medical advisory group has officially supported funding for integrating pharmacists into ACCHOs’ model of care.

 

Quotes attributable to PSA National President Dr Fei Sim FPS

 

“Through the IPAC project, pharmacists have proven how valuable we are in improving the health outcomes of Aboriginal and Torres Strait Islander peoples’ health. 

 

“One-third of pharmacists involved in the IPAC project were contracted from community pharmacies, highlighting further opportunities for capacity building initiatives within the pharmacy sector to collaboratively deliver better health outcomes for Aboriginal and Torres Strait Islander people.

 

“PSA is proud to have co-designed the Deadly pharmacists: foundation training for pharmacists working within Aboriginal Community-Controlled Health Services, which more than 900 pharmacists have accessed since its launch in late 2022, but we must continue to work together to improve health outcomes for Aboriginal and Torres Strait Islander people.

 

Quotes attributable to the Chair of NACCHO Donnella Mills

 

“Having the support of MSAC confirms when pharmacists are present within our services, both patients and staff at the clinic are better supported to provide safe and effective use of medicine. 

 

“Our member services have been calling for support and funding for non-dispensing pharmacists integrated into ACCHOs for years, this endorsement further validates their requests and demonstrates the impact of team-based community-controlled healthcare.

 

“Now that support for funding for pharmacists integrated into ACCHOs has been provided through the advisory committee, we look forward to working with government on how it can be rolled-out nationally.”

 

Quotes attributable to PSA National President Dr Fei Sim FPS

 

“Both NACCHO and PSA are ready and willing to work with the Federal Government to implement a collaborative model of care which meets the needs of the Aboriginal and Torres Strait Islander people and is consistent with the Federal Government’s commitment to the Priority Reforms of the National Closing the Gap Agreement.”

 

 

Media Contacts:

 

Georgia Clarke (PSA)  M: 0410 505 315     E: georgia.clarke@psa.org.au

Verity Leach (NACCHO) M: 0438 944 113 E: Verity.Leach@naccho.org.au

Pharmacists now able to dispense medical terminations medicines across Australia

11 July 2023

 

The Pharmaceutical Society of Australia (PSA) welcomes the Therapeutic Goods Administration’s decision to remove restrictions that prevent health professionals, including doctors and pharmacists, from prescribing and dispensing MS-2 Step (mifepristone and misoprostol).

 

From 1 August 2023, pharmacists will no longer need to be registered or undertake specific training to dispense MS-2 Step to patients across Australia.

 

PSA National President Dr Fei Sim FPS welcomes the move, noting that it will significantly improve women’s access to healthcare.

 

“This move will improve the access to care for women, making MS-2 step available in more pharmacies and in more communities in Australia.

 

“This approach recognises that pharmacists are medicine experts, and that dispensing MS-2 Step and counselling patients on its use is already within the scope of practice of pharmacists.

 

“By removing unnecessary red tape, pharmacists can help more Australian women access reproductive care, in line with international experience.

 

“Pharmacists follow a robust process to ensure all medicines are dispensed safely and effectively.

 

“Community pharmacists are the most accessible healthcare professional for many Australians and play a critical role to ensure women’s equitable access to reproductive care, especially in rural and remote areas.

 

“As the Co-Chair of the Access, Care and Outcomes Subcommittee of the National Women’s Health Advisory Council chaired by Assistant Minister for Health and Aged Care Ged Kearney, I welcome this TGA decision to improve women’s access to reproductive care.”

 

 

Media contact:   Georgia Clarke  

M: 0480 099 798  E: georgia.clarke@psa.org.au

Health Minister Mark Butler to open PSA23

5 July 2023 

 

The Pharmaceutical Society of Australia (PSA) has today announced that Federal Minister for Health and Aged Care the Hon Mark Butler MP will attend PSA23 in Sydney on 28 July 2023.

 

PSA23 is Australia’s leading education conference for pharmacists, attended by hundreds of industry leaders, academics and researchers, and pharmacists from all practice settings.

 

PSA National President Dr Fei Sim FPS said that there had never been a more important time for the Minister to address pharmacists.

 

“I am pleased to confirm that Minister Butler will address pharmacists directly as part of PSA23,” Dr Sim said.

 

“This will be the first time that Minister Butler addresses pharmacists since he announced the introduction of 60-day dispensing in April.

 

“PSA23 will be an opportunity for pharmacists to hear directly from the Minister for Health and Aged Care, as well as the Assistant Minister for Rural and Regional Health Emma McBride on the significant policy changes impacting our profession.”

 

PSA23 will see attendance from both sides of politics. Shadow Minister for Health and Aged Care Senator Anne Ruston will also be addressing attendees on Saturday 29 July.

 

For more information on PSA23 and the conference program, visit www.psa23.com.au

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

ACT Pharmacists win expanded scope

27 June 2023

 

The Pharmaceutical Society of Australia’s (PSA) campaign to expand scope of practice for pharmacists paid off this week, with new authorisations announced by the ACT Government.

 

Under yesterday’s legislative update, pharmacists in the ACT are authorised to administer medicines for injection, including Long-Acting Injectable Buprenorphine (LAIB).

 

The PSA’s ACT Branch President Olivia Collenette said the landmark change, which would enhance patient access to vital injectable medications, came after a lot of campaigning.

 

“We have long championed expansion of pharmacist scope of practice and, while there is still a long way to go, this is a significant step,” she said.

 

“We are thrilled that our advocacy on this particular issue has borne fruit, signalling a brighter future for pharmacy and reinforcing our commitment to advancing patient-centred care.”

 

The PSA has already provided comprehensive training on administering medicines by injection.

 

Pharmacists are encouraged to access these resources to ensure they are equipped with the necessary knowledge and skills to provide optimal care.

 

“PSA encourages all pharmacists in the ACT to familiarise themselves with the updated regulations and embrace this progressive expansion of their professional capabilities,” Ms Collenette said.

 

“By staying informed and ensuring adherence to best practices, pharmacists will continue to play a pivotal role in enhancing patient outcomes and promoting public health.”

 

For more information on the administration of medicines for injection by pharmacists in the ACT, visit:

 

Pharmacist Vaccinations and Injectables | Health (act.gov.au)

 

 

Protected: PSAmplified Hot Issues

This content is password protected. To view it please enter your password below:

Students to compete at National Pharmacy Competition (PSOTY)

23 June 2023

 

The Pharmaceutical Society of Australia (PSA) today announced the state and territory finalists for the 2023 Viatris Pharmacy Student of the Year (PSOTY) award, with the prestigious national final to take place at PSA’s National Conference PSA23 in July.

 

During the national final, students will be tested with a real-life clinical situation, where a patient will present with symptoms or a specific product request. Students are then required to use their clinical knowledge and communication skills to identify the most appropriate course of over-the-counter treatment, tailoring their response to provide the most appropriate advice.

 

A judging panel assesses all state finalists before selecting the national winner to be announced at PSA23’s Gala Dinner.

 

PSA National President Dr Fei Sim FPS congratulated the finalists, saying that the awards encourage students to draw on their clinical knowledge and emotional intelligence to demonstrate their skills.

 

“The Pharmacy Student of the Year awards showcase the skills and abilities of some of our outstanding pharmacy students to the broader profession, while also giving students a chance to apply their skills and be judged on them.

 

“Award sponsor Viatris and PSA are proud to sponsor the finalists to attend PSA23, providing travel and accommodation to ensure that they can get the most out of the leading pharmacist education conference.

 

“The Pharmacy Student of the Year will also receive a $3,000 cash prize to support their studies and pharmacy careers.

 

“Congratulations to all the students who’ve participated in the competition this year for their hard work and commitment to pharmacy.

 

“It’s exciting to see such talented students entering our profession and dedicating their lives to the health and wellbeing of their communities,” Dr Sim said.

 

The 2023 PSA Viatris Pharmacy Student of the Year finalists are:

  • Jamie-Lee Carew, the University of Newcastle
  • Sarah Foster, LaTrobe University
  • Kennith Lam, Curtin University
  • Samantha Montgomery, Queensland University of Technology
  • Claire Ryan, University of Tasmania
  • Brett Spicer, University of Canberra
  • Amelia Thompson, University of South Australia

 

 

They will also be joined by Ingrid Stoud from the University of Canberra, who was awarded the Wildcard winner at the 2023 National Australian Pharmacy Students Association Congress in January.

 

PSA extends thanks to the PSOTY award sponsor, Viatris, for their ongoing support and wishes all finalists the best of luck at the national final.

 

Find out more about the PSA Pharmacy Student of the Year competition by visiting www.psa.org.au/psoty 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

 

 

NOTICE: Upcoming my.psa.org.au website maintenance on Wednesday May 14th. Learn more...
+